Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-01-25 @ 5:21 AM
Study NCT ID:
NCT04772235
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2021-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
Sponsor:
Instituto Oncológico Dr Rosell
Organization: